ID27198A - Anhidrat dan monohidrat n-(3-etunilfenilamino)-6,7-bis (2-metoksietoksi)-4-kuinazolinamina mesilat - Google Patents
Anhidrat dan monohidrat n-(3-etunilfenilamino)-6,7-bis (2-metoksietoksi)-4-kuinazolinamina mesilatInfo
- Publication number
- ID27198A ID27198A IDW20002186A ID20002186A ID27198A ID 27198 A ID27198 A ID 27198A ID W20002186 A IDW20002186 A ID W20002186A ID 20002186 A ID20002186 A ID 20002186A ID 27198 A ID27198 A ID 27198A
- Authority
- ID
- Indonesia
- Prior art keywords
- quuzazolinamine
- monohidrates
- etunilphenylamino
- mesilate
- anhydrates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8344198P | 1998-04-29 | 1998-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID27198A true ID27198A (id) | 2001-03-08 |
Family
ID=22178359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002186A ID27198A (id) | 1998-04-29 | 1999-04-08 | Anhidrat dan monohidrat n-(3-etunilfenilamino)-6,7-bis (2-metoksietoksi)-4-kuinazolinamina mesilat |
Country Status (42)
Country | Link |
---|---|
EP (1) | EP1076652B1 (xx) |
JP (1) | JP4652569B2 (xx) |
KR (1) | KR100668412B1 (xx) |
CN (2) | CN1298396A (xx) |
AP (1) | AP1252A (xx) |
AR (1) | AR018201A1 (xx) |
AT (1) | ATE295839T1 (xx) |
AU (1) | AU759691C (xx) |
BR (1) | BR9910025A (xx) |
CA (1) | CA2330447C (xx) |
CO (1) | CO5060467A1 (xx) |
CZ (1) | CZ298230B6 (xx) |
DE (1) | DE69925366T2 (xx) |
DZ (1) | DZ2777A1 (xx) |
EA (1) | EA002836B1 (xx) |
EG (1) | EG24000A (xx) |
ES (1) | ES2238825T3 (xx) |
GT (1) | GT199900063A (xx) |
HK (1) | HK1037180A1 (xx) |
HN (1) | HN1999000057A (xx) |
HU (1) | HU227569B1 (xx) |
ID (1) | ID27198A (xx) |
IL (1) | IL139172A0 (xx) |
MA (1) | MA26624A1 (xx) |
ME (1) | MEP42008A (xx) |
MX (1) | MXPA00010610A (xx) |
MY (1) | MY136033A (xx) |
NO (1) | NO317301B1 (xx) |
NZ (1) | NZ508154A (xx) |
OA (1) | OA11769A (xx) |
PA (1) | PA8471001A1 (xx) |
PE (1) | PE20000441A1 (xx) |
PL (1) | PL196940B1 (xx) |
RS (1) | RS50081B (xx) |
SA (1) | SA99200216B1 (xx) |
TN (1) | TNSN99079A1 (xx) |
TR (1) | TR200003166T2 (xx) |
TW (1) | TWI248437B (xx) |
UA (1) | UA60363C2 (xx) |
UY (1) | UY26099A1 (xx) |
WO (1) | WO1999055683A1 (xx) |
ZA (1) | ZA992972B (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6706721B1 (en) | 1998-04-29 | 2004-03-16 | Osi Pharmaceuticals, Inc. | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
YU13200A (sh) | 1999-03-31 | 2002-10-18 | Pfizer Products Inc. | Postupci i intermedijeri za dobijanje anti-kancernih jedinjenja |
US7087613B2 (en) | 1999-11-11 | 2006-08-08 | Osi Pharmaceuticals, Inc. | Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
UA74803C2 (uk) * | 1999-11-11 | 2006-02-15 | Осі Фармасьютікалз, Інк. | Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування |
UA73993C2 (uk) * | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
EP1408980A4 (en) | 2001-06-21 | 2004-10-20 | Ariad Pharma Inc | NEW QUINAZOLINES AND THEIR USE |
US7078409B2 (en) | 2002-03-28 | 2006-07-18 | Beta Pharma, Inc. | Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
GB0223854D0 (en) * | 2002-10-12 | 2002-11-20 | Astrazeneca Ab | Therapeutic treatment |
US7148231B2 (en) * | 2003-02-17 | 2006-12-12 | Hoffmann-La Roche Inc. | [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph |
CA2527680A1 (en) | 2003-05-30 | 2005-06-02 | Astrazeneca Uk Limited | Markers for responsiveness to an erbb receptor tyrosine kinase inhibitor |
DE602004009097T2 (de) | 2003-06-10 | 2008-06-19 | F. Hoffmann-La Roche Ag | 1.3.4-triaza-phenalen- und 1,3,4,6-tetraazaphenalen-derivate |
GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
CA2565721C (en) | 2004-05-06 | 2015-10-06 | Bioresponse, L.L.C. | Diindolymethane formulations for the treatment of leiomyomas |
ATE497762T1 (de) | 2004-12-30 | 2011-02-15 | Bioresponse Llc | Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus |
WO2008012105A1 (en) | 2006-07-28 | 2008-01-31 | Synthon B.V. | Crystalline erlotinib |
US8586621B2 (en) | 2006-10-27 | 2013-11-19 | Michael A. Zeligs | Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles |
EP2139868B1 (en) * | 2007-04-04 | 2015-07-29 | Cipla Limited | Process for preparation of erlotinib and its pharmaceutically acceptable salts |
EP2162444B1 (en) | 2007-07-11 | 2014-06-04 | Hetero Drugs Limited | An improved process for the preparation of erlotinib hydrochloride |
WO2009024989A2 (en) | 2007-08-17 | 2009-02-26 | Hetero Drugs Limited | A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b |
KR101132937B1 (ko) * | 2008-10-01 | 2012-04-06 | 주식회사종근당 | N-(3-에티닐페닐)-6,7-비스(2-메톡시에톡시)-4-퀴나졸린아민 납실레이트 염 |
US8440823B2 (en) | 2009-03-26 | 2013-05-14 | Ranbaxy Laboratories Limited | Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof |
WO2011068404A2 (en) | 2009-12-02 | 2011-06-09 | Ultimorphix Technologies B.V. | Administration of n-(3-ethynylphenylamino)-6,7-bis(2- methoxyethoxy)-4-quinazolinamine mesylate salt by inhalation |
DE202010006543U1 (de) | 2010-05-07 | 2010-09-09 | Ratiopharm Gmbh | Erlotinibresinat |
HU230483B1 (hu) | 2011-10-10 | 2016-07-28 | Egis Gyógyszergyár Nyrt. | Erlotinib sók |
NZ630289A (en) | 2012-09-04 | 2016-08-26 | Shilpa Medicare Ltd | Crystalline erlotinib hydrochloride process |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ243082A (en) * | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
JP2994165B2 (ja) * | 1992-06-26 | 1999-12-27 | ゼネカ・リミテッド | キナゾリン誘導体、その製造法および該キナゾリン誘導体を含有する抗癌作用を得るための医薬調剤 |
GB9323290D0 (en) * | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
EP0817775B1 (en) * | 1995-03-30 | 2001-09-12 | Pfizer Inc. | Quinazoline derivatives |
US5747498A (en) * | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
-
1999
- 1999-04-08 CZ CZ20003974A patent/CZ298230B6/cs not_active IP Right Cessation
- 1999-04-08 IL IL13917299A patent/IL139172A0/xx not_active IP Right Cessation
- 1999-04-08 ID IDW20002186A patent/ID27198A/id unknown
- 1999-04-08 TR TR2000/03166T patent/TR200003166T2/xx unknown
- 1999-04-08 RS YUP-661/00A patent/RS50081B/sr unknown
- 1999-04-08 HU HU0101818A patent/HU227569B1/hu unknown
- 1999-04-08 EA EA200001112A patent/EA002836B1/ru not_active IP Right Cessation
- 1999-04-08 DE DE69925366T patent/DE69925366T2/de not_active Expired - Lifetime
- 1999-04-08 PL PL343766A patent/PL196940B1/pl not_active IP Right Cessation
- 1999-04-08 MX MXPA00010610A patent/MXPA00010610A/es active IP Right Grant
- 1999-04-08 BR BR9910025-8A patent/BR9910025A/pt not_active Application Discontinuation
- 1999-04-08 EP EP99909165A patent/EP1076652B1/en not_active Expired - Lifetime
- 1999-04-08 CA CA002330447A patent/CA2330447C/en not_active Expired - Lifetime
- 1999-04-08 AU AU28509/99A patent/AU759691C/en not_active Expired
- 1999-04-08 NZ NZ508154A patent/NZ508154A/en not_active IP Right Cessation
- 1999-04-08 KR KR1020007011998A patent/KR100668412B1/ko not_active IP Right Cessation
- 1999-04-08 ME MEP-420/08A patent/MEP42008A/xx unknown
- 1999-04-08 AT AT99909165T patent/ATE295839T1/de not_active IP Right Cessation
- 1999-04-08 CN CN99805497A patent/CN1298396A/zh active Pending
- 1999-04-08 OA OA1200000300A patent/OA11769A/en unknown
- 1999-04-08 WO PCT/IB1999/000612 patent/WO1999055683A1/en active IP Right Grant
- 1999-04-08 JP JP2000545843A patent/JP4652569B2/ja not_active Expired - Lifetime
- 1999-04-08 ES ES99909165T patent/ES2238825T3/es not_active Expired - Lifetime
- 1999-04-08 CN CNA2008100051101A patent/CN101219999A/zh active Pending
- 1999-04-23 TW TW088106555A patent/TWI248437B/zh not_active IP Right Cessation
- 1999-04-26 HN HN1999000057A patent/HN1999000057A/es unknown
- 1999-04-27 PA PA19998471001A patent/PA8471001A1/es unknown
- 1999-04-27 MY MYPI99001636A patent/MY136033A/en unknown
- 1999-04-27 AR ARP990101942A patent/AR018201A1/es active IP Right Grant
- 1999-04-28 ZA ZA9902972A patent/ZA992972B/xx unknown
- 1999-04-28 TN TNTNSN99079A patent/TNSN99079A1/fr unknown
- 1999-04-28 DZ DZ990077A patent/DZ2777A1/xx active
- 1999-04-28 MA MA25557A patent/MA26624A1/fr unknown
- 1999-04-29 EG EG48299A patent/EG24000A/xx active
- 1999-04-29 CO CO99026003A patent/CO5060467A1/es unknown
- 1999-04-29 GT GT199900063A patent/GT199900063A/es unknown
- 1999-04-29 AP APAP/P/1999/001523A patent/AP1252A/en active
- 1999-04-29 PE PE1999000356A patent/PE20000441A1/es not_active Application Discontinuation
- 1999-06-02 SA SA99200216A patent/SA99200216B1/ar unknown
- 1999-08-04 UA UA2000116681A patent/UA60363C2/uk unknown
-
2000
- 2000-04-05 UY UY26099A patent/UY26099A1/es not_active Application Discontinuation
- 2000-10-27 NO NO20005453A patent/NO317301B1/no not_active IP Right Cessation
-
2001
- 2001-08-17 HK HK01105821A patent/HK1037180A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID27198A (id) | Anhidrat dan monohidrat n-(3-etunilfenilamino)-6,7-bis (2-metoksietoksi)-4-kuinazolinamina mesilat | |
ID28787A (id) | 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya | |
ID19824A (id) | Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya | |
ID26964A (id) | Komposisi dan metode untuk pengaturan pengaktifan limfosit | |
ATE417847T1 (de) | Chinazolin- und pyridopyrimidinderivate | |
ATE446389T1 (de) | Enzymgemisch | |
ID26099A (id) | Turunan amida dan antagonis nosiseptin | |
ID23575A (id) | Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina | |
ID26599A (id) | Turunan triazola dan imidazola | |
NO984956D0 (no) | Brenner | |
EE200200175A (et) | Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine | |
BR9712544B1 (pt) | Inibidores de proteases de serina, composição farmacêutica compreendendo os mesmos e seus usos | |
ID22889A (id) | Komposisi kopolimer etilena dan penggunaannya | |
DE59711118D1 (de) | Spickeln, Zunehmen und Mindern | |
ID30393A (id) | Senyawa tienopirimidina, pembuatan dan penggunaannya | |
DE60043283D1 (de) | Pflasterstein und dazugehörige legemethode | |
ID28997A (id) | Kedok sekali pakai, dan proses pembuatannya | |
DE69903961D1 (de) | Muscarinagonisten und antagonisten | |
ID30417A (id) | Popok sekali pakai dan proses pembuatannya | |
DE69916694D1 (de) | 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on | |
NO20000746L (no) | Brenner | |
DE69820256D1 (de) | Fahrtreppenstufe und fahrtreppe | |
DE69841337D1 (de) | Hebestrukturen und anordnungen dafür | |
DE69930946D1 (de) | Thermokopf, thermokopfeinheit und herstellungsverfahren dafür | |
DE59809195D1 (de) | Gebläsebrenner |